S 2620

0likes☆Favorite🔕SubscribeShare

Introduced ↻ Update bill dataRe-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click. Contact your reps Urge the sponsor

IN THE SENATE OF THE UNITED STATES

July 31, 2025

Mr. Durbin (for himself and Mr. Cassidy) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Reforming Evergreening and Manipulation that Extends Drug Years Act” or the “REMEDY Act”.

SEC. 2. AMENDMENTS TO ANDA APPROVAL PROVISIONS.

Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.

355) is amended—

(1) in subsection (c)(2) by adding at the end the following: “With respect to a drug approved on or after the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, when a holder of an approved application first files information under this paragraph with respect to one or more patents described in subsection (b)(1)(A)(viii), the holder shall select one such patent with respect to which the owner or licensee may be eligible for the thirty-month period under paragraph (3)(C) or subsection (j)(5)(B)(iii), as applicable; for purposes of paragraphs (3)(C) and (3)(E)(ii) and subsections (j)(5)(B)(iii) and (j)(5)(F)(ii), such patent shall be referred to as the ‘covered patent’. The selection of such covered patent may not be changed or amended.”;

(2) in subsection (c)(3)(C)—

(A) in the matter preceding clause (i)—

(i) by striking “an action is brought for infringement” and all that follows through the period at the end of the first sentence and inserting “with respect to a drug approved under this subsection before the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of any patent that is the subject of the certification and for which information was submitted to the Secretary under paragraph (2) before the date on which the application (excluding an amendment or supplement to the application) was submitted, or, with respect to a drug approved under this subsection on or after the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of the covered patent (as described in paragraph (2)) that is the subject of the certification and for which information was submitted to the Secretary under paragraph (2) before the date on which the application (excluding an amendment or supplement to the application) was submitted.”; and

(ii) by striking “an action is brought before” and inserting “an action with respect to a patent or a covered patent, as applicable, is brought before”; and

(B) in clause (i), by striking “decides that the patent” and inserting “decides that the patent or the covered patent, as applicable”;

(3) in the second sentence of subsection (c)(3)(E)(ii), by inserting “with respect to any patent for which the requirements are met for the thirty-month period described in subparagraph (C)” after “action for patent infringement”;

(4) in subsection (j)(5)(B)(iii)—

(A) in the matter preceding subclause (I)—

(i) by striking “an action is brought for infringement” and all that follows through the period at the end of the first sentence and inserting “with respect to a drug approved under subsection (c) before the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of any patent that is the subject of the certification and for which information was submitted to the Secretary under subsection (c)(2) before the date on which the application (excluding an amendment or supplement to the application), which the Secretary later determines to be substantially complete, was submitted, or, with respect to a drug approved under subsection (c) on or after the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of the covered patent (as described in subsection (c)(2)) that is the subject of the certification and for which information was submitted to the Secretary under subsection (c)(2) before the date on which the application (excluding an amendment or supplement to the application), which the Secretary later determines to be substantially complete, was submitted.”; and

(ii) by striking “an action is brought before” and inserting “an action with respect to a patent or a covered patent, as applicable, is brought before”; and

(B) in subclause (I), by striking “decides that the patent” and inserting “decides that the patent or covered patent, as applicable,”; and

(5) in the second sentence of subsection (j)(5)(F)(ii), by inserting “with respect to any patent for which the requirements are met for the thirty-month period described in subparagraph (B)(iii),” after “action for patent infringement”. <all>